ANTI-CLAUDIN 18.2 ANTIBODIES AND USES THEREOF
申请(专利)号： WO2019US20872
专利号： WO2019173420A1 主分类号： A61K39/395
申请日： 2019-03-06 公开公告日： 2019-09-12
分类号： A61K39/395;
C07K16/28; C07K16/30; C07K16/32 发明设计人： WANG, MINGHAN;
ZOU, HUI; JIA, HAIQUN 申请国代码： US
优先权： 20180308 US
62/640,288; 20180803 US 62/714,254
摘 要 附 图：
申请权利人： PHANES
THERAPEUTICS, INC. 公开国代码： WO 优先权国家： US
摘 要：
Anti-CLDN18.2 antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, and methods of producing the antibodies and using the antibodies for treating or preventing diseases such as cancer and/or an inflammatory disease. 主权项：
CLAIMS /n It is claimed: /n 1. An isolated monoclonal antibody or antigen-binding fragment thereof c
权 利 要 求 说 明 书
【ANTI-CLAUDIN 18.2 ANTIBODIES AND USES THEREOF】的权利说明书内容是......请下载后查看
说 明 书
【ANTI-CLAUDIN 18.2 ANTIBODIES AND USES THEREOF】的说明书内容是......请下载后查看
ANTI-CLAUDIN 18.2 ANTIBODIES AND USES THEREOF
